Axios Pro Rata spotlights regulatory shift, IPO preparations, big VC rounds
Axios Pro Rata reports key developments: proposals are emerging to shift public companies from quarterly to semi-annual disclosures under a new SEC push. Meanwhile, TCG (formerly The Chernin Group) is becoming a permanent capital vehicle, signaling a shift in PE/VC structures. Recent VC raises include €308M for Tubulis, $120M for Pelage Pharmaceuticals, and $105M for Ecorobotix. Also of note: Cardinal Infrastructure filed for IPO, and deal volumes in PE and software remain elevated amid resurgence in capital deployment.
neutral
1 day ago
Axios Pro Rata spotlights regulatory shift, IPO preparations, big VC rounds
Axios Pro Rata reports key developments: proposals are emerging to shift public companies from quarterly to semi-annual disclosures under a new SEC push. Meanwhile, TCG (formerly The Chernin Group) is becoming a permanent capital vehicle, signaling a shift in PE/VC structures. Recent VC raises include €308M for Tubulis, $120M for Pelage Pharmaceuticals, and $105M for Ecorobotix. Also of note: Cardinal Infrastructure filed for IPO, and deal volumes in PE and software remain elevated amid resurgence in capital deployment.
neutral
Axios Pro Rata spotlights regulatory shift, IPO preparations, big VC rounds
1 day ago
1 min read
78 words
Policy shift on disclosures, big VC rounds, and new IPO filings dominate Axios Pro Rata.
Axios Pro Rata reports key developments: proposals are emerging to shift public companies from quarterly to semi-annual disclosures under a new SEC push. Meanwhile, TCG (formerly The Chernin Group) is becoming a permanent capital vehicle, signaling a shift in PE/VC structures. Recent VC raises include €308M for Tubulis, $120M for Pelage Pharmaceuticals, and $105M for Ecorobotix. Also of note: Cardinal Infrastructure filed for IPO, and deal volumes in PE and software remain elevated amid resurgence in capital deployment.
Axios Pro Rata reports key developments: proposals are emerging to shift public companies from quarterly to semi-annual disclosures under a new SEC push. Meanwhile, TCG (formerly The Chernin Group) is becoming a permanent capital vehicle, signaling a shift in PE/VC structures. Recent VC raises include €308M for Tubulis, $120M for Pelage Pharmaceuticals, and $105M for Ecorobotix. Also of note: Cardinal Infrastructure filed for IPO, and deal volumes in PE and software remain elevated amid resurgence in capital deployment.